SAN FRANCISCO, February 19, 2018 /PRNewswire/ --
The global cardiac rhythm management (CRM) devices market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies by governments in developed and developing countries. Rising incidence of cardiovascular diseases (CVDs), supportive reimbursement scenario, and major advancements in technology are also anticipated to be key factors governing market growth.
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
CRM devices serve as a permanent treatment option for patients suffering from arrhythmias. Innovation in Cardiac Resynchronization Therapy (CRT) devices is expected to drive this market. Additionally, there is an increase in the application of implantable cardioverter-defibrillators (ICDs) as they are now integrated with pacemakers, thus increasing the product's life. Increase in demand for external defibrillators with growing in awareness and rising disease burden of sudden cardiac arrest (SCA) has also been observed. There is an expansion in the market for external defibrillators as governments in developed economies have been working on making countries more cardio-friendly.
According to statistics published by the Sudden Cardiac Arrest Foundation, about 6.0 million people within the U.S. region suffer from cardiac disorders, of which 0.8 million are affected by atrioventricular blockage, leading to cardiac failure. Such an alarming number leads to an increased cost of about USD 20-56 billion annually. CRM devices are being predominantly used to prevent surgical costs and readmission rates in hospitals, thereby propelling market growth.
Browse full research report with TOC on "Cardiac Rhythm Management (CRM) Devices Market Share, Size & Trends Analysis Report By Product (Pacemaker, Defibrillator, Cardiac Resynchronization Therapy), And Segment Forecasts, 2014 - 2025" at: https://www.grandviewresearch.com/industry-analysis/cardiac-rhythm-management-devices-industry
Further Key Findings From the Report Suggest:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Advertisement
The global cardiac rhythm management (CRM) devices market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies by governments in developed and developing countries. Rising incidence of cardiovascular diseases (CVDs), supportive reimbursement scenario, and major advancements in technology are also anticipated to be key factors governing market growth.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
CRM devices serve as a permanent treatment option for patients suffering from arrhythmias. Innovation in Cardiac Resynchronization Therapy (CRT) devices is expected to drive this market. Additionally, there is an increase in the application of implantable cardioverter-defibrillators (ICDs) as they are now integrated with pacemakers, thus increasing the product's life. Increase in demand for external defibrillators with growing in awareness and rising disease burden of sudden cardiac arrest (SCA) has also been observed. There is an expansion in the market for external defibrillators as governments in developed economies have been working on making countries more cardio-friendly.
According to statistics published by the Sudden Cardiac Arrest Foundation, about 6.0 million people within the U.S. region suffer from cardiac disorders, of which 0.8 million are affected by atrioventricular blockage, leading to cardiac failure. Such an alarming number leads to an increased cost of about USD 20-56 billion annually. CRM devices are being predominantly used to prevent surgical costs and readmission rates in hospitals, thereby propelling market growth.
Browse full research report with TOC on "Cardiac Rhythm Management (CRM) Devices Market Share, Size & Trends Analysis Report By Product (Pacemaker, Defibrillator, Cardiac Resynchronization Therapy), And Segment Forecasts, 2014 - 2025" at: https://www.grandviewresearch.com/industry-analysis/cardiac-rhythm-management-devices-industry
Further Key Findings From the Report Suggest:
- Defibrillators held a lucrative share in 2016 and are also likely to grow at a profitable rate over the forecast period due to increase in prevalence of CVDs. These devices are normally used as continuous monitoring devices for arrhythmias
- North America accounted for more than 35.0% of the overall market in 2016. This can be attributed to increasing incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes available to patients, growing awareness, and rise in training programs
- Asia Pacific was observed to be the fastest growing market for CRM devices with a CAGR nearly 9.0%. This is owing to increasing awareness and accessibility of CRM devices
- Some of the key players operating in this space are St. Jude Medical; BIOTRONIK, Inc.; Medtronic; Boston Scientific Corporation; and ZOLL Medical Corporation.
- Atherectomy and Thrombectomy Devices Market - The Global atherectomy and thrombectomy devices market is expected to witness lucrative growth over the forecast period.
- Dental Equipment Market - The Global dental equipment market size was estimated at USD 6,081.4 million in 2013. Rising geriatric population has led to the high prevalence of age-related dental disorders, hence propelling the growth of this industry.
- Enteral Feeding Devices Market - The global enteral feeding devices market was valued at USD 1,813.7 million in 2013 and is expected to grow at a CAGR of 6.0% during the forecast period to reach USD 2,720.8 million by 2020.
- Burn Care Market - The global burn care market size was estimated at USD 1.66 billion in 2016. Increasing incidence of burn-related injuries is the major factor driving the market growth over the forecast period.
- CRM Devices Product Outlook (Revenue, USD Million, 2014 - 2025)
- Pacemakers
- Implantable Pacemakers
- External Pacemakers
- Defibrillators
- Implantable Cardioverter Defibrillators (ICDs)
- Subcutaneous ICD (S-ICD)
- Transvenous ICD (T-ICD)
- External Defibrillator (ED)
- Manual ED
- Automated ED (AED)
- Wearable Cardioverter Defibrillator
- Implantable Cardioverter Defibrillators (ICDs)
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillators (CRT-D)
- CRT-Pacemakers (CRT-P)
- Pacemakers
- CRM Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East and Africa (MEA)
- South Africa
- North America
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
